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RnA-Seq analysis of ileocecal valve 
and peripheral blood from Holstein 
cattle infected with Mycobacterium 
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CXCL8/IL8 signaling pathway
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paratuberculosis is chronic granulomatous enteritis of ruminants caused by Mycobacterium avium 
subsp. paratuberculosis (MAp). Whole RnA-sequencing (RnA-Seq) is a promising source of novel 
biomarkers for early MAp infection and disease progression in cattle. Since the blood transcriptome 
is widely used as a source of biomarkers, we analyzed whether it recapitulates, at least in part, the 
transcriptome of the ileocecal valve (icV), the primary site of MAp colonization. total RnA was prepared 
from peripheral blood (pB) and icV samples, and RnA-Seq was used to compare gene expression 
between animals with focal or diffuse histopathological lesions in gut tissues versus control animals 
with no detectable signs of infection. Our results demonstrated both shared, and PB and ICV-specific 
gene expression in response to a natural MAP infection. As expected, the number of differentially 
expressed (De) genes was larger in the icV than in the pB samples. Among the De genes in the pB 
and icV samples, there were some common genes irrespective of the type of lesion including the C-
X-C motif chemokine ligand 8 (CXCL8/IL8), apolipoprotein L (APOLD1), and the interferon inducible 
protein 27 (IFI27). The biological processes (BP) enriched in the PB gene expression profiles from the 
cows with diffuse lesions included the killing of cells of other organism, defense response, immune 
response and the regulation of neutrophil chemotaxis. two of these Bp, the defense and immune 
response, were also enriched in the ICV from the cows with diffuse lesions. Metabolic analysis of the 
De genes revealed that the n-glycan biosynthesis, bile secretion, one-carbon pool by folate and purine 
metabolism were significantly enriched in the ICV from the cows with focal lesions. In the ICV from cows 
with diffuse lesions; the valine, leucine and isoleucine degradation route, purine metabolism, vitamin 
digestion and absorption and the cholesterol routes were enriched. Some of the identified DE genes, 
Bp and metabolic pathways will be studied further to develop novel diagnostic tools, vaccines and 
immunotherapeutics.
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Johne’s disease or paratuberculosis (PTB) is a chronic granulomatous enteritis of ruminant animals caused by 
Mycobacterium avium subsp. paratuberculosis (MAP). Transmission of MAP primarily occurs by the fecal-oral 
route through the ingestion of MAP contaminated feces, colostrum, or milk. Infection usually occurs within 
the first months of live of the animal but remains subclinical for an average of 2–5 years. After being ingested, 
MAP crosses the intestinal mucosa where it is phagocytosed by sub-epithelial macrophages establishing a chronic 
infection1. MAP is able to survive and proliferate within phagosomes by inhibiting apoptosis and phagosomal 
acidification and by preventing presentation of antigens to the immune system2. As the infection progresses, the 
lesions in the intestine and mesenteric lymph nodes become more severe. Rather than localized, the granuloma-
tous infiltrate becomes diffuse disrupting the mucosal structure and function and affecting jejunum and ileum3,4. 
Although understanding the immunological mechanisms leading to the various outcomes of MAP infection 
remains problematic, there is no doubt that the interaction of Mycobacteria with the innate immune system plays 
a central role in the disease pathogenesis5.
PTB is responsible for significant economic losses in dairy herds worldwide due to decreased milk produc-
tion, increased management costs and premature culling from clinical disease6–9. Furthermore, there is some 
evidence suggesting that MAP infection might be associated with Crohn’s disease (CD) in humans10. Several 
studies have demonstrated that more than 50% of the dairy cattle herds are positive for MAP antibodies in USA 
and in Europe and, therefore, bovine PTB can be considered endemic in these areas11,12. Commercial inactivated 
vaccines against bovine PTB are very successful in reducing MAP presence in feces and tissues and in increasing 
both milk production and cattle productive life in infected farms13,14. However, PTB vaccination with heat-killed 
inactivated vaccines is not allowed in most European countries due to its interference with Mycobacterium bovis 
detection tests15. Therefore, PTB control is currently based on testing and culling plus preventing MAP trans-
mission to susceptible animals using appropriate hygienic-sanitary strategies16,17. However, the efficiency of the 
control programs based on the “test and cull” policy is strongly conditioned by the sensitivity of the tests used to 
identify early infections. Presently, fecal culture is considered “the gold standard” test for the ante-mortem diag-
nosis of MAP infection18. However, individual fecal culture is expensive and time consuming and only detects 
advanced infections due to the relatively late onset of fecal shedding during the natural course of MAP infection. 
In fact, the sensitivity of the fecal culture is 70% in animals with PTB-associated clinical signs, but only 23–29% in 
animals with subclinical infection, which may shed MAP intermittently and in lower numbers in feces and milk 
contaminating the environment and infecting other animals19. Early stage diagnostics such as the IFN-γ release 
assay detects whether a T-cell mediated immune response has been elicited in response to mycobacterial antigens 
but only reflects MAP exposure, and thus cannot discriminate between individuals with controlled infection from 
those with subclinical disease20. It is clear that the detection of subclinical infections before the bacterium is shed 
and transmitted to herd mates and possibly to humans remains a challenge and, therefore, novel tools are needed 
to detect MAP-infected animals at early stages of the infection.
Transcriptomic profiling is a promising source of novel biomarkers for early MAP infection in cattle, for 
monitoring the progress of the disease, and for the search of immune markers that can be used in the design of 
therapeutics and vaccines21. RNA-Sequencing (RNA-Seq) gives a quantitative and qualitative view of the tran-
scriptomic profile of the tissues or cells being studied. Previous RNA-Seq analysis examined the transcriptome of 
bovine monocyte-derived macrophages (MDM) infected with MAP and revealed putative biomarkers for early 
infection22,23. To date only one study has used RNA-Seq to examine the transcriptome of ICV samples collected 
from dairy cows naturally infected with MAP24. Some of the subclinical animals included in this study did not 
show any specific evidence of MAP infection and no pathways controlling the immune response appeared to be 
affected in this animal group. The authors concluded that perhaps with deeper sequencing in further experiments, 
potential biomarkers could be ascertained. Since the peripheral blood (PB) is the most available physiological 
fluid for the detection of biomarkers, in the current study we examined whether it recapitulates, at least in part, 
the transcriptome of the ileocecal valve (ICV), the primary site of MAP colonization. For this purpose, RNA-Seq 
was used to identify host genes differentially expressed (DE) in ICV and PB samples collected from PTB-infected 
animals with focal or diffuse lesions in gut tissues versus control animals. Gene expression data were interpreted 
using gene ontology (GO) categories and metabolic pathways containing multiple DE genes. Overall, our study 
provides insights into how cattle respond to a natural MAP infection in two targets, ICV and PB, and revealed 
common and unique biological processes activated in animals with early and more advanced PTB-associated 
lesions.
Results
Summary of the RnA-Seq data. The animals included in our study were tested by multiple diagnostic 
tests including histopathological analysis of gut tissues, acid-fast stain, specific antibody response to MAP, fecal 
qPCR and tissue and fecal bacteriological culture. The results of the premortem (at the annual sampling time) and 
post-mortem (at the time of slaughter) diagnostic tests are showed in Table 1. All control animals (n = 3) showed 
a negative result for all diagnostic tests. Culling of control animals was due to age, accident, and coxofemoral 
luxation. All the infected cows included in our study had detectable lesions in gut tissues with distinct severity, 
focal or diffuse. At the slaughter time, the animals with focal lesions in gut tissues (n = 6) showed a negative fecal 
culture result but were fecal PCR positive (1/6), ELISA positive (1/6), and/or had evidence of MAP infection in 
gut tissues by ZN (1/6), PCR (5/6) and/or bacteriological culture (2/6). None of the animals with focal lesions had 
a heavy bacterial load (>50 cfu/gr) in feces and tissues and none of them was culled due to paratuberculosis-asso-
ciated clinical signs. In contrast, the cows with diffuse histopathological lesions in gut tissues (n = 5) were culled 
due to a positive ELISA or PCR result (2/5), or because they showed PTB-associated clinical signs, including low 
milk production (1/5) or profuse diarrhea and weight loss (2/5). At the slaughter time, all of the cows with diffuse 
lesions had a positive ZN and ELISA result, a PCR-positive result in feces and tissue samples, and had a positive 
bacteriological culture from gut tissues. The mean amount of MAP estimated by qPCR in the gut tissues of all the 
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animals with diffuse lesions was >66765 copies of MAP/gr tissue while the mean bacterial load in the gut tissue 
samples of the animals with focal lesions was ˂ 30528 copies of MAP/gr tissue.
RNA-Seq libraries were prepared from PB and ICV of 14 animals within the three categories; with focal or dif-
fuse histopathological lesions in gut tissues and control. Duplicate RNA extractions and corresponding RNA-Seq 
libraries were generated from PB and ICV samples of five of the 14 cows (ID 2, 6, 8, 11, 12) to check the repro-
ducibility of the RNA-Seq technology. The RNA-Seq data summary for each biological sample and experimental 
replicate including number of reads per individual RNA-Seq library at each phase of the analysis is provided in 
Supplementary Table I. All the libraries were sequenced generating an average of de 22.31 million raw reads per 
library with a Phred quality score >30 which is considered a benchmark for quality in next-generation sequenc-
ing. Following filtering of reads based on quality score, minimum size of 60 bp and ambiguous base N percentage 
less than 5%, an average of 21.44 million reads remained. Alignment of the filtered RNA-Seq reads to the Bos 
taurus reference genome yielded mean values per library of 19.96 million reads. From the mapped reads, an 
average of 5% of the reads mapped to multiple locations in the genome and were excluded for gene expression 
analysis. A more detailed analysis of the reads mapping to unique locations was obtained using bedtools and 
featureCounts, two software packages developed for counting reads to genomic features such as upstream and 
downstream regions of genes, exons, introns and intergenic regions. Analysis of the individual library reads from 
the PB samples revealed that 57% of the reads aligned to exons, 28% to introns, 3% to intergenic regions, 2% 
to upstream regions and 10% to downstream regions. In the ICV samples, introns accounted for 24% of reads, 
exons for 63% of the reads, 2% of the aligned reads mapped intergenic regions, 1% upstream regions and 10% 
downstream regions.
Analysis of differential gene expression from RNA-Seq data. Although high technical reproduc-
ibility has been claimed for the RNA-Seq technology25,26, we performed duplicate RNA extractions and corre-
sponding RNA-Seq library preparations from PB and ICV samples of some of the animals (ID 2, 6, 8, 11, 12). 
Variations in this experiment could arise from the RNA preparation, fragmentation or priming method, ligation 
efficiencies, amplification and other variables in the technical steps of library construction and amplification. 
After performing gene expression analysis as describe in materials and methods, no significant differences were 
observed between each sample and corresponding replicate which support the reproducibility of gene expression 
studies using RNA-Seq (Supplementary Fig. 1).
The DE genes (FDR < 0.05) between cows with focal or diffuse histopathological lesions versus control cows 
are presented as red dots in Fig. 1a. The number of DE genes was higher in the ICV samples than in the PB sam-
ples and increased in animals with diffuse histopathological lesions when compared with the group of animals 
with focal lesions. This was expected since diffuse lesions represent a more advanced stage of the disease. In the 
PB samples, 109 and 207 genes were DE in the comparisons between animals with focal or diffuse lesions and 
control cows, respectively (Fig. 1b). Data analysis revealed 51 DE genes that were common in the PB samples 
regardless of the type of lesion. The transcriptomic analysis of the ICV samples showed that 3189 and 4724 genes 
were DE in the animals with focal or diffuse lesions when compared with control animals, respectively. Between 
these two comparisons, 2557 genes were DE in the ICV samples of the MAP-infected cows regardless of the 
comparison. A total of 19 DE genes were common among the animals with focal lesions regardless of the tested 
sample, ICV or PB. Similarly, 89 genes appeared DE in the PB and ICV samples of the animals with diffuse lesions.
ID
Histopathological analysis ELISA (OD) Fecal PCR Fecal culture (CFUs) Gut tissues
Microscopic Macroscopic ZN Pre-mortem At slaughter Pre-mortem At slaughter
Pre-
mortem
At 
slaughter PCR Culture
1 Negative No Neg Neg (1.26) Neg (1.93) Neg Neg Neg Neg Neg Neg
2 Negative No Neg Neg (2.77) Neg (8.54) Neg Neg Neg Neg Neg Neg
3 Negative No Neg Neg (8.99) Neg (2.45) Neg Neg Neg Neg Neg Neg
4 Focal No Neg ND Neg (2.71) ND Neg ND Neg Pos (0.38) Neg
5 Focal No Neg Neg (1.00) Neg (1.03) Neg Neg Neg Neg Pos (7.50) Low
6 Focal No Neg Neg (4.39) Neg (5.51) Neg Neg Neg Neg Pos (305.28) Neg
7 Focal No Neg Neg (4.92) Neg (0.74) Pos (0.03) Neg Neg Neg Pos (12.26) Neg
8 Focal No Neg Pos (95.85) Pos (133.17) Neg Pos Neg Neg Pos (70.54) Medium
9 Multifocal Yes Pos Neg (0.00) Neg (2.97) Neg Neg Neg Neg Neg Neg
10 Diffuse paucibacillary Yes Pos Neg (53.00) Pos (283.13) Neg Pos Neg Neg Pos (667.65) Heavy
11 Diffuse intermediate Yes Pos Pos (142.31) Pos (187.69) Pos (0.14) Pos (0.14) Neg Neg Pos (3896.19) Heavy
12 Diffuse intermediate Yes Pos Pos (174.01) Pos (241.18) Pos (7.50) Pos (114.00) Neg Heavy Pos (104032) Heavy
13 Diffuse intermediate Yes Pos Neg (32.19) Pos (288.75) Pos (1.41) Pos (39.88) Neg Neg Pos (1572.24) Low
14 Diffuse multibacillary Yes Pos Pos (286.51) Pos (255.55) Pos (11.70) Pos (2832.00) Neg Neg Pos (173316.00) Heavy
Table 1. Histopathological analysis, ZN stain, ELISA, PCR and bacteriological culture results from all the 
animals included in the current study. Neg, Negative; Pos, Positive; ZN, Ziehl-Neelsen; OD, Optical Density; 
CFU, Colony Forming Units; ND, No Determined. DNA samples with a PCR-positive result using the LSI 
VetMax Triplex real-time PCR were quantified using the ParaTB Kuanti-VK kit. qPCR results are expressed as 
MAP DNA copies per gram of feces or tissues × 102.
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Gene expression comparison between animals with ptB-associated histophalogical lesions 
versus control cows. A total of 109 and 207 were DE in the PB samples of the animals with focal or diffuse 
lesions when compared with the control animals, respectively. Among these DE genes, 21 and 48 were upregu-
lated in each comparison, respectively (Table 2). Table 3 shows the top five upregulated and top-five downregu-
lated genes in the PB samples of the animals with focal lesions versus control samples ranked by fold-change. The 
top five upregulated genes included the ATP binding cassette subfamily A member 13 (ABCA13), a receptor for 
class I MHC antigens named Leukocyte immunoglobulin-like receptor subfamily A member 6 (LOC618416) and 
three still uncharacterized proteins. The top five genes downregulated in the PB samples from the animals with 
focal lesions versus control cows were: the C-C motif chemokine ligand 14 (CCL14), Insulin-like growth factor 2 
mRNA binding protein 3 (IGF2BP3), Osteoglycin (OGN), Glycogen phosphorylase muscle associated (PYGM), and 
the CD5 antigen-like precursor (CD5L). Many of the top ranked DE genes have immune-related functions such 
LOC618416, CD5L and CCL14; being the last two genes downregulated. The CD5L is a secreted protein expressed 
by macrophages in lymphoid and inflamed tissues that acts as a key regulator of lipid synthesis. CCL14 is a chem-
otactic factor that attracts T-cells and monocytes, but nor neutrophils, eosinophils, or B-cells. Fold change in the 
downregulated genes ranged from −4.5 to −1.1, with a mean fold change of −2.0. For the upregulated genes, the 
fold change of expression ranged between 3.7 to 1.0 with a mean log fold of 1.7.
RNA-Seq analysis detected 207 DE genes in the PB samples of the cows with diffuse lesions compared to the 
control group. A total of 48 out of the 207 DE genes were upregulated (mean fold change of 2.1, range between 
3.8 to 1.3) and 159 downregulated (mean fold change of −2.3, range between −1.1 to −7.7). The top five upreg-
ulated genes in the PB samples of the animals with diffuse lesions when compared with control animals were: 
Two pore channel 3 (TPC3), Creatine kinase M-type (CKM), Desmin (DES), Myosin light chain 2 (MYL2) and an 
a. Peripheral blood Ileocecal valve
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Figure 1. RNA-seq analysis. (a) Volcano plots showing the DE genes (log2 fold change) versus –log (p value) 
for each comparison. The red spots represent the DE genes in each comparison. (b) Venn diagram showing 
transcriptional changes between the groups comparisons based on RNA-Seq data.
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uncharacterized protein (Table 3). The top five downregulated genes in this comparison were: the Cathelicidins 
3 and 4 (CATHL3 and CATHL4), CD177 molecule (CD177), C-C motif Chemokine ligand 14 (CCL14), and the 
Multidrug resistance-associated protein 4-like. CATHL3 and CATHL4 exert a potent antimicrobial activity due to 
an impairment of the function of the respiratory chain and of energy-dependent activities in the inner membrane 
of susceptible microorganisms. CD177 is a neutrophil G-protein-linked surface glycoprotein.
RNA-Seq analysis revealed that 3189 and 4724 genes were dysregulated in the ICV samples from the animals 
with focal or diffuse lesions versus de control group, respectively (Table 2). The top five upregulated genes in the 
ICV of cows with focal lesions were the Intelectin 2 precursor (ITLN2), Cholecystokinin (CCK), Homeobox B13 
(HOXB13), Fatty acid binding protein 6 (FABP6) and Heat shock protein family A member 6 (HSPA6). The upregu-
lated genes mean fold change of expression was 1.5 but, in this case there were larger differences in the expression 
levels between genes, having the most upregulated gene a fold change of 10.6 and the less upregulated one a fold 
change of 0.6. CCK is a peptide hormone that induces gall bladder contraction and release of pancreatic enzymes 
in the gut. HOXB3 is a transcriptional factor previously implicated with inflammation. FABP6 is involved in the 
gastric acid and pepsinogen secretion and is also required for efficient apical to basolateral transport of conju-
gated bile acids in ileal enterocytes. The top five downregulated genes were two uncharacterized proteins, the 
Duodenase-1-like with both trypsin‐like and chymotrypsin‐like activities, Tumor suppressor candidate 5 (TUSC5), 
and the Aquaporin 8 (AQP8) (Table 3). Mean fold change of the downregulated genes was −1.1 with values rang-
ing between −6.7 and −0.6.
In the ICV samples, a total of 4724 DE genes were identified in the comparison between the animals with 
diffuse lesions versus the control group. From these 4724 DE genes, 1473 genes were upregulated and 3251 were 
downregulated (Table 2). The level of gene expression was similar between the up- and downregulated genes as 
demonstrated by the log2 fold changes. The upregulated genes on average showed a 1.2 fold increase between the 
cows with diffuse lesions and the control group (range between 6.8 to 0.5), whereas the downregulated genes 
averaged a −1.2 fold decrease between groups (range between −8.3 to −0.5). The top five upregulated genes 
included the Intelectin 2 precursor (ITLN2), Heat shock protein family A member 6 (HSPA6), Immunoglobulin 
superfamily member 23 (IGSF23), Apolipoprotein B (APOB) and the Carbamoyl-phosphate synthase 1 (CPS1). On 
the other hand, the top five downregulated genes were the Lysozyme C milk isozyme 1 (LYZ1), Adiponectin C1Q 
(ADIPOQ), Lysozyme C intestinal isozyme (LYSB), Acyl-CoA synthetase medium chain family member 1 (ACSM1) 
and the Aquaporin 8 (AQP8). Several of the downregulated genes in this comparison such as the ITLN2, LYZ1, 
LYSB and ADIPOQ play important roles in the defense response against pathogens. Lysozymes such as LYZ1 and 
LYSB have primarily a bacteriolytic function. ADIPOQ is an adiponectin involved in the control of the fat metab-
olism and it has an anti-inflammatory activity by negatively regulating TNF-α expression in macrophages, and 
also by counteracting its effects.
common gene expression signatures in the pB and icV samples of MAp-infected animals. DE 
gene analysis revealed that 51 genes were DE in the PB of the MAP-infected animals regardless of the severity of 
the lesion (Table 2). Similarly, 2557 genes were DE in the ICV gene expression profiles from the infected cows 
versus the control group. The PB and ICV gene expression profiles from the cows with focal lesions shared 19 
DE genes, and 89 DE genes were common in the PB and ICV expression profiles of the cows with diffuse lesions. 
In Table 4 we show the top three upregulated and downregulated genes in the PB and/or ICV gene expression 
profiles from MAP-infected animals. The Oxidized low density lipoprotein receptor (ORL1) and the Tweety family 
protein 2 (TTYH2) appeared both upregulated in the PB samples of the MAP-infected cows, regardless of the 
severity of their lesions in gut tissues. The CCL14 chemokine, an epithelial-derived chemokine with antibacterial 
properties, was the most downregulated gene in the PB gene expression profile from MAP-infected cows versus 
the control group.
In the ICV samples, the ITLN2 precursor showed the highest transcription increase in the cows with both 
focal and diffuse lesions; log2 fold-change was 10.6 and 6.8, respectively. Immunohistochemistry provided further 
evidence of the ITLN2 production and localization in ICV. As seen in Fig. 2, ITLN2 expression increases upon 
infection with MAP compared to control samples. Goblet cells and Paneth cells along the ICV from the infected 
animals were intensively labeled with the bovine ITLN2 antibody. FABP6, a gastrotropin involved in the efficient 
apical to basolateral transport of conjugated bile acids in ileal enterocytes was highly upregulated in the ICV gene 
Sample Comparison
DE genes 
(N)
Up-regulated 
genes (N)
Down-regulated 
genes (N)
Comparison 
specific DE 
genes (N)
Up-regulated 
genes (N)
Down-regulated 
genes (N)
PB Focal vs Control 109 21 88 37 11 26
PB Diffuse vs. Control 207 48 159 82 21 61
PB Focal vs. Control + Diffuse vs. Control 51 6 45 30 4 26
ICV Focal vs. Control 3189 168 3021 620 68 552
ICV Diffuse vs. Control 4724 1473 3251 2105 1321 784
ICV Focal vs. Control + Diffuse vs. Control 2557 96 2446 2505 93 2397
PB, ICV Focal vs. Control 19 0 18 2 0 2
PB, ICV Diffuse vs. Control 89 20 49 33 17 12
PB, ICV Focal vs. Control + Diffuse vs. Control 5 0 4 5 0 4
Table 2. Differentially expressed (DE) genes and specific DE genes for each comparison.
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expression profile from the infected cows irrespective of the severity of the histopathological lesions. The stress 
response protein, HSPA6, was also highly expressed in the ICV from MAP-infected cows with log2 fold-changes 
of 4.2 and 5.8 in the gene expression profiles of the cows with focal or diffuse lesions versus control cows, respec-
tively. A significant reduction in the expression of the AQP8 gene, a protein involved in water/solute intestine 
homeostasis, was observed in the ICV gene expression profile from the cows with focal or diffuse lesions versus 
the control group; log2 fold-change = −3.2 and −4.5, respectively.
Several genes involved in the control of infectious diseases such as the Basic leucine zipper ATF transcription 
factor 2 (BATF2) and the C-X-C motif chemokine ligand 10 (CXCL10), were upregulated in the PB and ICV gene 
expression profiles from the animal with diffuse lesions. BATF2 belongs to the activator protein 1 (AP-1) tran-
scription factor family and interacts with the IFN regulatory factor 1 to mediate downstream proinflammatory 
immune responses. CXCL10 is chemotactic for monocytes and T-lymphocytes by binding to CXCR3. C4b-binding 
protein alpha-like, epiregulin (ERG) and the CXCL8/IL8 were downregulated in the PB and ICV gene expression 
profiles from cows with diffuse lesions versus the control group.
Five genes were DE in the PB and ICV gene expression profiles from the animals with PTB-associated his-
topathological lesions irrespective of the type of lesion including the CXCL8/IL8, Apolipoprotein L domain 
Sample Comparison Gene ID Description
Fold Change 
(Log2)a
PB
Focal vs. Control
ENSBTAG00000003531 ATP binding cassette A member 13 (ABCA13) 3.7
ENSBTAG00000039691 Uncharacterized protein 2.7
ENSBTAG00000039086 Uncharacterized protein 2.6
ENSBTAG00000000930 Uncharacterized protein 2.2
ENSBTAG00000019348 leukocyte Ig-like receptor subfamily A member 6 2.0
ENSBTAG00000022514 CD5 antigen-like precursor (CD5L) −3.6
ENSBTAG00000001032 Glycogen phosphorylase,muscle associated (PYGM) −3.8
ENSBTAG00000011824 Osteoglycin (OGN) −3.9
ENSBTAG00000019406 Insulin growth factor 2 binding protein 3 (IGF2BP3) −4.0
ENSBTAG00000010738 C-C motif chemokine ligand 14 (CCL14) −4.5
Diffuse vs. Control
ENSBTAG00000046419 Two pore channel 3 (TPC3) 3.8
ENSBTAG00000013921 Creatine kinase, M-type (CKM) 3.8
ENSBTAG00000005353 Desmin (DES) 3.7
ENSBTAG00000046611 Uncharacterized protein 3.6
ENSBTAG00000018369 Myosin light chain 2 (MYL2) 3.6
ENSBTAG00000047764 multidrug resistance-associated protein 4-like −5.1
ENSBTAG00000010738 C-C motif chemokine ligand 14 (CCL14) −5.3
ENSBTAG00000002976 CD177 molecule (CD177) −5.4
ENSBTAG00000031599 Cathelicidin-3 (CATHL3) −7.4
ENSBTAG00000020072 Cathelicidin-4 (CATHL4) −7.7
ICV
Focal vs. Control
ENSBTAG00000022937 Intelectin 2 precursor (ITNL2) 10.6
ENSBTAG00000013027 Cholecystokinin (CCK) 6.3
ENSBTAG00000014663 Homeobox B13 (HOXB13) 5.8
ENSBTAG00000010632 Fatty acid binding protein 6 (FABP6) 4.2
ENSBTAG00000039035 Heat shock protein 70 family A member 6 (HSPA6) 4.2
ENSBTAG00000020184 Aquaporin 8 (AQP8) −3.2
ENSBTAG00000019379 Tumor suppressor candidate 5 (TUSC5) −3.2
ENSBTAG00000046611 Uncharacterized protein −3.6
ENSBTAG00000013055 Duodenase-1-like −3.6
ENSBTAG00000047008 Uncharacterized protein −6.7
Diffuse vs. Control
ENSBTAG00000022937 Intelectin 2 precursor (ITLN2) 6.8
ENSBTAG00000039035 Heat shock protein family 70A member 6 (HSPA6) 5.8
ENSBTAG00000048075 Ig superfamily member 23 (IGSF23) 5.1
ENSBTAG00000008505 Apolipoprotein B (APOB) 4.8
ENSBTAG00000016662 Carbamoyl-phosphate synthase 1 (CPS1) 4.8
ENSBTAG00000020184 Aquaporin 8 (AQP8) −4.5
ENSBTAG00000001417 Acyl-CoA synthetase medium chain 1 (ACSM1) −4.7
ENSBTAG00000026323 Lysozyme C, intestinal isozyme (LYSB) −5.3
ENSBTAG00000019813 Adiponectin, C1Q (ADIPOQ) −5.8
ENSBTAG00000011941 Lysozyme C, milk isozyme (LYZ1) −8.3
Table 3. The top five up- and downregulated DE genes in samples from MAP-infected cows versus control 
samples. aA negative fold-change value reports downregulated gene expression.
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containing 1 (APOLD1), Interferon α-inducible protein 27 (IFI27), KIAA1324 like (KIAA1324L) and ArfGAP with 
RhoGAP domain, ankyrin repeat and PH domain 2 (ARAP2). CXCL8/IL8, APOLD1, KIAA1324L and ARAP2 
were downregulated in all the comparisons. The ARAP2 gene is thought to play a major role in the activation of 
the major histocompatibility complex class II genes expression27. The IFI27 was downregulated in the PB samples 
and upregulated in the ICV samples from the cows with focal (log2 fold = 1.6) and diffuse lesions (log2 fold = 2.6) 
when compared with the control group. The IFI27 (ISG12) mediates IFN-induced apoptosis characterized by a 
rapid and robust release of cytochrome C from the mitochondria and activation of caspases 2,3,6,8 and 9 which 
may in turn influence the antiviral activities of the IFN28.
Gene ontology (Go) analysis. Functional categorization of the DE genes in each comparison was per-
formed using the Bioconductor GOseq package to identify biological process (BP), cellular component (CC) and 
molecular function (MF) (Table 5). While in the PB samples of the cows with focal lesions we did not identify 
Sample Comparison Gen ID Description (Gene Symbol) Lesion
Fold Change 
(Log2)a
PB Focal vs. Control + Diffuse vs. Control
ENSBTAG00000019348 Uncharacterized protein Focal 2.0
Diffuse 1.6
ENSBTAG00000004547 Oxidized low density lipoprotein receptor1 (OLR1) Focal 1.1
Diffuse 2.3
ENSBTAG00000011007 Tweety family member 2 (TTYH2) Focal 1.3
Diffuse 1.7
ENSBTAG00000001032 Glycogen phosphorylase (PYGM) Focal −3.8
Diffuse −2.7
ENSBTAG00000019406 Insulin growth factor2 mRNA binding prot3 (IGF2BP3) Focal −4.0
Diffuse −2.8
ENSBTAG00000010738 C-C motif chemokine ligand 14 (CCL14) Focal −4.5
Diffuse −5.3
ICV Focal vs. Control + Diffuse vs. Control
ENSBTAG00000022937 Intelectin 2 precursor (ITLN2) Focal 10.6
Diffuse 6.8
ENSBTAG00000010632 Fatty acid binding protein 6 (FABP6) Focal 4.2
Diffuse 4.7
ENSBTAG00000039035 Heat shock protein family A member 6 (HSPA6) Focal 4.2
Diffuse 5.8
ENSBTAG00000047181 Multidrug resistance-associated protein 4 Focal −3.2
Diffuse −2.3
ENSBTAG00000020184 Aquaporin 8 (AQP8) Focal −3.2
Diffuse −4.5
ENSBTAG00000013055 Duodenase-1-like Focal −3.6
Diffuse −2.0
PB + ICV
Focal vs. Control
ENSBTAG00000036154 TCR gamma alternate reading frame protein (TARP) Blood −2.8
ICV −1.1
ENSBTAG00000002362 Apolipoprotein L domain containing 1 (APOLD1) Blood −2.6
ICV −1.1
ENSBTAG00000038080 Duodenase-1 Blood −2.2
ICV −1.9
Diffuse vs. Control
ENSBTAG00000011467 Basic ATF transcription factor2 (BATF2) Blood 2.6
ICV 2.8
ENSBTAG00000001725 C-X-C motif chemokine ligand 10 (CXCL10) Blood 2.0
ICV 2.2
ENSBTAG00000046803 Growth arrest specific 1 (GAS1) Blood 2.4
ICV 1.1
ENSBTAG00000039196 C4b-binding protein alpha-like Blood −4.8
ICV −2.0
ENSBTAG00000010273 Epiregulin (EREG) Blood −4.8
ICV −2.0
ENSBTAG00000019716 C-X-C motif chemokine ligand 8 (CXCL8) Blood −3.9
ICV −1.9
Table 4. The top 3 up- and downregulated genes in the PB and/or ICV samples of infected animals with focal 
and/or diffuse lesions versus control samples. aA negative fold-change value reports downregulated gene 
expression.
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any significantly overexpressed GO, eleven GOs were significantly enriched in the PB samples of the animals with 
diffuse lesions. Out of these eleven GO; 5 were BP, 4 were CC and 2 were MF (Fig. 3a). The five identified BP were 
related to the immune response, including killing of cells of other organisms (GO:0031640), defense response 
(GO:0006952, GO:0050832), immune response (GO:0006955) and positive regulation of neutrophil chemotaxis 
(GO:0090023). The enriched CC identified in the PB samples of cows with diffuse lesions were the extracellular 
space and cell membrane.
We identified 83 and 80 overrepresented GO in the ICV samples of the cows with focal and diffuse lesions, 
respectively. The top 11 GOs identified in the ICV samples of the animals with focal and diffuse lesions were 
CC. Enriched CC in the ICV samples of the cows with both focal and diffuse lesions included the cytosol and 
the cytoplasm being these the top dysregulated CC. Among the top five BP enriched in the ICV samples of the 
cows with focal lesions were the cellular response to DNA damage stimulus (GO:0006974), protein transport 
(GO:0015031), immune system process (GO:00023746), DNA repair (GO:0006281) and the neutrophil chemo-
taxis GO (GO:0030593) (Fig. 3b). Three of the top five overexpressed BP in the ICV from the cows with diffuse 
lesions were associated with the innate immune and inflammatory response (Fig. 3c). Interestingly, the defense 
response (GO:0006952) and immune response (GO:0006955), were both enriched in the PB and ICV gene 
expression profiles from the cows with diffuse lesions (Fig. 4). Our results revealed that the chemokines CXCL8/
IL8 and CXCL10 were regulated in opposite directions in cows with the more advanced lesions. While CXCL8/IL8 
was downregulated in the PB and ICV samples, CXCL10 was upregulated in both MAP-targeted samples from the 
cows with diffuse lesions. This differential modulation of CXCL10 and CXCL8/IL8 may suggest a different role of 
both chemokines in the infection. While CXCL8/IL8 attracts neutrophils, basophils and T-cells to the site of the 
infection, CXCL10 is chemotactic for monocytes and T-lymphocytes by binding to CXCR3. Expression changes 
in genes with antibacterial activity such as the Cathelicidin 6 (CATHL6) and β-defensin (DEFβ4A) were also 
observed. Seven DE genes included in the immune response pathway (GO:0006955) were dysregulated in the PB 
and ICV gene expression profiles from the cows with diffuse lesions including the CCL14, ENPP2, CD36, CXCL8/
IL8, BOLA-DQβ, MHC class I heavy chain and one uncharacterized protein (ENSBTAG00000040323). While 
MHC class I heavy chain was upregulated; ENPP2, CD36, CXCL8/IL8, and BOLA-DQβ were downregulated in 
the PB and ICV expression profiles from the cows with diffuse lesions when compared with the control group.
Metabolic analysis. Enriched metabolic routes related to the DE genes in each comparison were analyzed. 
Although no metabolic pathways referenced in the KEGG database were enriched in the PB samples, 78 and 
Figure 2. Localization of the Intelectin 2 (ITLN2) precursor in the ICV of MAP-infected versus control cows by 
immunohistochemistry. Sections of the ICV from animal without lesions (a,d), and with focal (b,e,g) or diffuse 
lesions (c,f,h) were labeled with an anti-bovine ITLN2 antibody and stained as explained in materials and 
methods. The arrows show sites of antibody binding. Bars are 50 µM.
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82 metabolic routes were dysregulated in the ICV samples of the cows with focal and diffuse lesions, respec-
tively. Only three of the 78 metabolic pathways dysregulated in the ICV gene expression profiles from the cows 
with focal lesions were significantly enriched including the N-Glycan biosynthesis (bta00510, P = 0.004), purine 
metabolism (bta00230, P = 0.015) and the one carbon pool by folate pathway (bta00670, P = 0.021). The meta-
bolic analysis using the DE genes in the ICV from cows with diffuse lesions versus the control group revealed that 
the DE genes in this comparison affected metabolic processes such as the valine, leucine and isoleucine degrada-
tion (bta00280, P = 0.008) and the purine metabolism (bta00230, P = 0.003) witch sequences corresponding to 10 
and 34 enzymes, respectively. Therefore, our metabolic analysis revealed bta00230 as a common metabolic route 
significantly enriched in the ICV from the infected cows versus the control cows. Using the STRING database, the 
bile secretion metabolic route (bta04976) was significantly enriched in the ICV from the cows with focal lesions 
(enrichment score = 244.99, FDR = 0.001) with 18 proteins involved in this network. In the ICV from the cows 
with diffuse lesions, the vitamin digestion and absorption (enrichment score = 599.07, FDR = 0.001) and the cho-
lesterol (enrichment score = 677.38, FDR = 0.001) routes were significantly enriched with six and four proteins 
matching each route, respectively.
protein to protein interaction analysis. Protein to protein interaction analysis using the DE genes in the 
PB samples from the animals with focal lesions revealed a HBEGF-CXCL8/IL8 functional association (Fig. 5a). 
Using the DE genes in the PB samples from the cows with diffuse lesions, 11 functional associations and two 
CXCL8/IL8 and Collagen type I, α2 chain (COL1A2) networks were identified (Fig. 5b). The COL1A2 was linked 
to a secreted protein, the Acidic and rich in cysteine protein (SPARC), the Syndecan 4 (SDC4) and to the Integrin 
subunit α9 (ITGA9). When the DE genes in the ICV gene expression profile from the cows with focal lesions 
were used, 13 functional interactions and one CXCL8/IL8 centered network were retrieved (Fig. 5c). With a 
confidence cuff of 0.7, 90 functional interactions and a centered mitogen-activated MAP kinase 8 (MAPK8) net-
work were retrieved when the DE genes in the ICV of the animals with diffuse lesions were used (Fig. 5d). Our 
protein-protein interaction analysis revealed that the interaction between MAPK8 and CXCL8/IL8 might be 
mediated by two leucine zipper protein members of the AP1 transcription factor complex, FOS and FOSB.
Discussion
Transcriptomic profiling of the host response to MAP infection has the potential to advance our understand-
ing of MAP-host interactions and to reveal the mechanisms involved in the establishment and progression of 
bovine PTB. This information can help to set up the basis for novel diagnosis tools and for the development of 
novel preventive and therapeutic approaches which could improve cattle health. Host transcriptomic studies have 
highlighted the importance to compare whole blood versus other issues. To our knowledge, our study represents 
the first attempt to study the specificities and common signatures of the ICV and PB gene expression profiles of 
PTB-infected cattle using RNA-Seq. All the infected cows included in our study had detectable lesions in gut 
tissues with distinct severity, focal or diffuse. Although the number of control animals is limited, our results 
showed extensive expression differences between infected and control cows. We found that the number of DE 
genes was higher in the ICV than in the PB samples and increased with the severity of the lesion. More specifi-
cally, our study revealed 19 genes DE in the PB and ICV gene expression profiles from the cows with focal lesions 
versus the control group. Similarly, 89 genes were DE in the PB and ICV gene expression profiles from the cows 
with diffuse lesions versus the control group. Interestingly, the most upregulated gene in the ICV samples of the 
infected animals was the ITLN2 precursor; log2 fold change = 10.6 and 6.8 in the cows with focal or diffuse lesions 
versus the control group, respectively. The ITLN2 is an extracellular lectin able to bind Mycobacterium tubercu-
losis and Mycobacterium bovis bacillus Calmette-Guerin (BCG)29. The FABP6, an ileum-specific bile acid (BA) 
transporter, was also highly upregulated in the ICV gene expression profile from the infected cows versus control 
cows which suggests a dysregulation of the BA secretion in MAP-infected animals. We also observed that MAP 
infection downregulated the expression of the BA receptor FXR in the ICV from the cows with focal and diffuse 
lesions versus control cows; log2 fold = −0.8 and −1.0, respectively. In agreement with our results, Hempel et al. 
Sample Comparison
Total 
enriched 
GO (N)
Enriched 
Biological 
process (N)
Enriched 
Cellular 
component (N)
Enriched 
Molecular 
function (N)
Specific 
enriched 
GO (N)
Enriched 
Biological 
process (N)
Enriched 
Cellular 
component (N)
Enriched 
Molecular 
function (N)
PB Focal vs. Control 0 0 0 0 0 0 0 0
PB Diffuse vs. Control 11 5 4 2 7 3 2 2
PB Focal vs. Control + Diffuse vs. Control 0 0 0 0 0 0 0 0
ICV Focal vs. Control 83 32 31 19 34 13 12 9
ICV Diffuse vs. Control 80 38 27 15 30 17 9 4
ICV Focal vs. Control + Diffuse vs. Control 48 19 18 11 47 19 17 11
PB, ICV Focal vs. Control 0 0 0 0 0 0 0 0
PB, ICV Diffuse vs. Control 3 2 1 0 2 2 0 0
PB, ICV Focal vs. Control + Diffuse vs. Control 0 0 0 0 0 0 0 0
Table 5. Number of enriched gene ontologies (GOs) and specific GOs for each comparison.
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found the FABP6 transporter as the top upregulated gene in the comparison of clinical versus uninfected con-
trol animals24. Apart from FABP6, we found other genes highly dysregulated in the ICV gene expression profile 
from the cows with diffuse lesions such as the Immunoglobulin superfamily member 23 (IGSF23) (log2 fold = 5.1), 
Apolipoprotein B (APOB) (log2 fold = 4.8), Solute carrier family 10 member 2 (SLC10A2) (log2 fold = 2.7), and the 
Matrix metallopeptidase 13 (MMP13) (log2 fold = 2.0) which had been previously reported by Hempel et al. in 
the comparison of clinical versus control cows. Little is known about the role of IGSF23, but other IGSF members 
are cell adhesion molecules that perform important immunological functions, including recognizing a variety of 
counterpart molecules on the cell surface or extracellular matrix30.
Several genes involved in the control of infectious diseases such as the basic leucine zipper transcription factor 2 
(BATF2) and CXCL10 chemokine were found in our study highly upregulated in the PB and ICV gene expression 
profiles from the cows with diffuse lesions versus the control group but were unaffected in the cows with focal 
lesions. BATF2 is predominantly expressed in monocytes and macrophages and has a central role in macrophage 
activation by regulating inflammatory responses during mycobacterial infection. In human tuberculosis (TB), 
BAFT2 has been suggested as a biomarker and a potential host directed drug target31,32. The CXCL10 chemokine, 
also known as IFN-γ inducible protein-10 (IP-10), is chemotactic for monocytes and T-lymphocytes by binding to 
CXCR3 receptor. CXCL10 is expressed mainly by activated CD14+ memory T cells, which produce a Th1 pattern 
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Figure 3. Gene ontology (GO) analysis using the DE genes in the two groups of infected cows compared to 
the control group. (a) The eleven GO enriched in the PB samples collected from the group of animals with 
diffuse lesions in gut tissues versus the control group. (b) The 11 top biological processes overrepresented in the 
ICV samples collected from the animals with focal lesions versus the control group. (c) The 11 top biological 
processes enriched in the ICV samples from the group of cows with diffuse lesions versus the control group.
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of cytokine production33. Several studies have demonstrated that CXCL10 can be used as a biomarker of TB, 
where significantly greater levels of mycobacterial antigen-induced CXCL10 protein were detected in whole blood 
of TB patients compared to healthy controls34–36. More recently, the simultaneously measurement of CXCL10 and 
IFN-γ enhanced test sensitivity for bovine TB identification in cattle in clinical stages of the infection37.
Our study revealed enrichment of the following GOs in the ICV from the cows with focal lesions: cellu-
lar response to DNA damage stimulus (GO:0006974), protein transport (GO:0015031), immune system pro-
cess (GO:0002376), DNA repair (GO:0006281) and neutrophil chemotaxis (GO:0030593). Three of the top five 
GO enriched in the ICV gene expression profile from the cows with diffuse lesions were associated with the 
innate immune response (GO:0045087), inflammatory response (GO:0006954) and the immune system pro-
cess (GO:0002376). Interestingly, the GOs related to the defense response (GO:0006952) and immune response 
(GO:0006955) were enriched in the PB and ICV from the cows with diffuse lesions. The DE genes included in 
the GO:0006952 were the CXCL8/IL8, CXCL10, CATHL6, and DEFβ4A. Seven DE genes corresponding to the 
immune response (GO:0006955) were dysregulated in both the PB and ICV gene expression profiles from the 
cows with diffuse lesions including CCL14, ENPP2, CD36, CXCL8/IL8, BOLA-DQβ, MHC class I heavy chain 
and the uncharacterized protein ENSBTAG00000040323. ENPP2, CD36, CXCL8/IL8, and BOLA-DQβ were 
downregulated in the PB and ICV from the cows with diffuse lesions when compared with the control group. 
Downregulation of members of the bovine major histocompatibility (MHC) class II genes can potentially alter 
antigen presentation and activation of T helper cells during MAP infection38. Our results showed reduced expres-
sion of BOLA-DOβ and BOLA-DQB genes in the PB from the cows with focal and diffuse lesions, respectively. In 
the ICV samples, the BOLA-DRα, BOLA-DMS, BOLA3, and the BOLA-DOB genes were downregulated in cows 
with focal lesions when compared with the control group. In contrast, in the ICV samples of the cows with diffuse 
lesions upregulation of the BOLA-DOα, BOLA-DMB, BOLA-DMA genes was detected which might suggest the 
activation of T helper cells as the infection progresses.
Interestingly, our study revealed CXCL8/IL8 as a common chemokine highly downregulated in our database 
and involved in the following pathways; neutrophil chemotaxis (GO:0030593), defense response (GO:0006952) 
and immune response (GO:0006955). Similarly, CXCL8/IL8 production was reduced in stimulated PB mononu-
clear cells from CD patients in comparison to healthy subjects and in MDM from Mycobacterium bovis-infected 
a.         Defense response b.         Immune response
C-X-C motif 
chemokine ligand 8 
(CXCL8)
Cathelicidin 6
(CTHL6)
Beta-defensin 4 
precursor
(DEFB4A)
C-X-C motif 
chemokine ligand 10 
(CXCL10)
C-C motif chemokine 
ligand 14 (CCL14)
Ectonucleotide
pyrophosphatase/
phosphodiesterase 2 
(ENPP2)
CD 36 molecule 
(CD36)
C-X-C motif 
chemokine ligand 8 
(CXCL8)
MHC, class II, DQ 
beta(BOLA-DQB)
MHC class I heavy 
chain
Uncharacterized 
protein
Figure 4. Enriched biological process in PB and ICV from the cows with diffuse lesions versus the control 
group. The defense response (GO:0006952) and immune response (GO:0006955) biological processes were 
both enriched in the PB and ICV gene expression profiles from the cows with diffuse lesions. The heatmaps 
represent the fold change (log2 fold) of the up- and downregulated genes included in the enriched GO:0006952 
and GO:0006955. Colors and intensities depend on expression levels. Red indicated gene downregulation and 
blue upregulation.
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cattle versus healthy control cattle39,40. Since the CXCL8/IL8 is the major chemokine responsible for neutrophil 
recruitment and activation by binding to CXCR3, decreased CXCL8/IL8 expression may reflect impairment of 
neutrophil recruitment and activation during a natural MAP infection. Other CXCL8/IL8-associated biological 
functions include plasma exudation, general granulocytophilia, degranulation of neutrophils, respiratory burst 
response, and mobilization of intra-cellular Ca2+ 41. In our study, the Epiregulin (ERG) and CXCL8/IL8 genes were 
both downregulated in the PB and ICV gene expression profiles from the cows with diffuse lesions versus control 
cows. ERG belongs to the epidermal growth factor (EGF) family together with the HBEGF; acting both as mito-
genic stimulators via binding to EGF receptors (EGFRs). Transactivation of EGFR leads to downstream signaling 
events including MAPK8 phosphorylation and activation which leads to apoptosis induction42. Induced CXCL8/
IL8 release is predominantly dependent on EGF binding to the EFGR leading to activation of MAPK843. Our 
protein-protein interaction analysis using the DE genes in the cows with diffuse lesions revealed a central role 
for CXCL8/IL8 and MAPK8 in MAP pathogenesis. This kinase was downregulated in the ICV gene expression 
profiles from the cows with focal and diffuse lesions when compared with the control group; −1.7 and −2.16938, 
respectively. Our results support the idea that MAP infection limits signaling via the MAPK8-IL8 expression 
pathway which may favor MAP survival. Although the role of CXCL8/IL8 in MAP pathogenesis has not been 
characterized before, the CXCL8/IL8 has been shown to play an important role in the pathogenesis of the human 
inflammatory bowel disease (IBD)33.
Our protein-protein interaction analysis using the DE genes in the PB from the cows with focal and diffuse 
lesions identified a CXCL8/IL8 network in both stages of the disease. In other hand, using the DE genes in the 
PB from the cows with diffuse lesions a COL1A2 centered network was identified containing a COL1A2-SPARC 
functional interaction. Interestingly, a SPARC-centered network was expressed more strongly in Mycobacterium 
bovis-challenged MDM from bovine TB infected cows that in uninfected cows44. SPARC, also known as 
Figure 5. Protein-protein network analysis using the DE genes (log2 fold > 2 and < 2) in the transcriptomic 
profiles of the cows with PTB-associated lesions versus the control group. (a) Using the DE genes in the PB 
samples from the animals with focal lesions, two HBEGF-IL8 and TAC3-F2RL3 functional interactions were 
detected. (b) In the PB samples from the cows with diffuse lesions, two IL8 and COL1A2 centered networks 
were observed. (c) When the DE genes in the ICV transcriptomic profiles of the cows with focal lesions were 
used, a IL8 centered network was also obtained. (d) A MAPK8 centered network was retrieved when the DE 
genes in the ICV transcriptomic profile of the cows with diffuse lesions were searched in the STRING database. 
Individual nodes represent proteins with relationships represented by edges. The confidence score (>0.7) of 
each interaction is mapped to the edge thickness. The proteins with no associations to other proteins in the 
networks were hidden.
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osteonectin, is a matrix protein that binds collagen, and it is required for the development of granuloma-like 
structures during chronic infections45. In our study, SPARC and COL1A2 were upregulated in the PB gene expres-
sion profiles from the cows with diffuse lesions which suggests that the expression of both proteins could lead to 
a bad prognosis in MAP-infected cows.
Recently, metabolomic analysis yielded a clear separation between non-infected and MAP-infected cattle, 
indicating changes in general metabolism, nutrition uptake and energy balance during the early stage of the dis-
ease46. Using RNA-Seq, we identified three metabolic pathways significantly enriched in the ICV from the cows 
with focal lesions including the N-Glycan biosynthesis (map00510, P = 0.004), purine metabolism (map00230, 
P = 0.015) and the one carbon pool by folate route (map00670, P = 0.021). Altered concentrations of N-glycans, 
such as mannose, were previously observed by the Buck et al. early after MAP infection46. In addition, it has been 
recently proposed that Mycobacterium tuberculosis infection manipulates the glycosylation machinery and the 
N-Glycoproteome of human macrophages47. The metabolic analysis performed using the DE genes in the ICV 
from the cows with diffuse lesions revealed enrichment of the branched amino acids (BCAA; valine, leucine and 
isoleucine) degradation (map00280, p = 0.008) and of the purine metabolism (map00230, p = 0.003). The deg-
radation of the BCAA in advanced stages of the infection is consistent with the fact that PTB eventually leads to 
intestinal malabsorption and hypoproteinemia in the final stages of the infection4. Interestingly, our study iden-
tified the purine metabolism as a common enriched route in the ICV gene expression profiles of MAP-infected 
cows regardless of the type of lesion. In agreement with our findings, a previous study showed that MAP infec-
tion increased intracellular ATP in bovine monocytes48. Using the STRING database, the bile secretion meta-
bolic route (bta04976) was significantly enriched in the ICV gene expression profiles from the cows with focal 
lesion (enrichment score = 244.99, FDR = 0.001). In the ICV gene expression profile from the cows with diffuse 
lesions, the cholesterol and the vitamin digestion and absorption routes were significantly enriched, respectively. 
In agreement with these findings, recent reports have demonstrated that MAP is able to manipulate the host lipid 
metabolism and accumulate cholesterol within macrophages which might favor MAP persistence49. In addition, 
decreases in serum 25-hydroxyvitamin D3 (25OHD3) levels were significantly lower in cows in the clinical stage 
of disease compared with either cows in the subclinical stage and non-infected control cows50. It is generally 
accepted that cattle in advanced stages of MAP infection are unable to metabolize and absorb vitamin D3 across 
the intestinal wall, and therefore suffer from weight loss and cachexia.
This study is the first to simultaneously describe transcriptomic changes in PB and ICV samples of cattle 
naturally infected with MAP. Several important observations were made. First, by comparing the transcriptomic 
profiles of two MAP-targeted tissues we described both unique and overlapping changes in the transcriptome of 
the infected cows versus the control group. Second, our study highlighted the ability of the RNA-Seq technology 
to reveal roles for genes that have not been previously implicated in the host response to MAP infection. Third, 
our transcriptomic analysis provided potential biomarkers for the development of future diagnostic tools, vac-
cines and therapeutics.
Materials and Methods
ethic statement. Experimental procedures performed on the animals used in this study were approved by 
the Animal Ethics Committee of the Servicio Regional de Investigation y Desarrollo Agroalimentario (SERIDA) 
and authorized by the Regional Consejeria de Agroganadería y Recursos Autoctonos of the Principality of 
Asturias (approval code PROAE 29/2015). All the procedures were carried out in accordance with the European 
Guidelines for the Care and Use of Animals for Research Purposes (2012/63/EU). PB and fecal samples were 
collected by trained personnel and in accordance with good veterinary practice.
Animal population. Fourteen Holstein Friesian cows from a single commercial dairy farm in Asturias 
(Spain) were monitored annually by obtaining PB and fecal samples to assess disease status by ELISA, and fecal 
bacteriological culture and PCR. The mean prevalence of the disease in the farm estimated by ELISA was 6.29% 
in the sampling period (2016–2018).
tissue and fecal sampling for histopathology, immunohistochemistry and bacterial culture. 
For histopathological analysis, samples from ileocecal lymph nodes, distal jejunal lymph node, ICV, and dis-
tal jejunum were collected aseptically from each animal and placed in formalin. The collected samples were 
fixed in 10% neutral buffered formalin, and dehydrated through graded alcohols and xilol before being embed-
ded in paraffin wax. Several sections were cut from each tissue sample using a microtome Leica RM2035 (Leica 
Mycrosystems, Barcelona, Spain), mounted on treated microscope slides (Fisher Scientific Co) and subsequently 
stained with hematoxylin-eosin (HE) and Ziehl-Neelsen (ZN). The stained sections were examined under a 
microscope Olympus BX51 equipped with an Olympus U-CMAD3 digital camera for pathological lesions and 
for the presence of acid-fast bacteria (AFB). According to their location and extension, inflammatory cell type, 
and Mycobacterial load, PTB-associated histopathological lesions were classified as focal (focal and multifocal), 
and diffuse (paucibacillary, intermediate or multibacillary)3.
For immunohistochemistry, the Avidin-Biotin kit with peroxidase-based detection was used (Vector 
Laboratories, California, USA). Briefly, ICV sections were deparaffinised, hydrated and rinsed with tap water. 
Afterwards, slides were treated to quench the endogenous peroxidase by incubation with methanol containing 3% 
H2O2 for 10 min at room temperature and washed with water for 10 min. The tissue sections were incubated over-
night at 4 °C with an anti-ITLN2 polyclonal antibody (Aviva Systems Biology, San Diego, California), washed with 
TBS and incubated with a goat biotinylated anti-rabbit IgG (1:200 dilution). The sections were then incubated 
with VECTASTAIN Elite ABC Reagent for 30 min at room temperature. Finally, the sections were incubated with 
3,3-diaminobenzidine tetrahydrochloride (DAB, Sigma, St. Louis, MO, USA) for 5 min and washed with TBS. The 
stained slides were dehydrated, mounted and studied under light microscopy.
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For bacteriological culture, a pool (2 gr) of ileocecal lymph nodes, distal jejunal lymph node, ICV, and distal 
jejunum were decontaminated with 38 mL of hexa-decyl pyridinium chloride at a final concentration of 0.75% 
(Sigma, St. Louis, MO) and homogenized in a stomacher blender. After 30 min of incubation at room tempera-
ture, 15 mL of the suspension was transferred to a new tube and incubated overnight for decontamination and 
sedimentation. Approximately, 200 µl of the suspension was taken from the layer near the sediment and inocu-
lated into two slants of Herrolds egg yolk medium (HEYM; Becton Dickinson, Sparks, MD) and into two slants 
of Lowenstein-Jensen medium (LJ; Difco, Detroit, MI), both supplemented with Mycobactin J (Allied Monitor, 
Fayette, MO) as previously described51. Bacterial load in tissues was classified as low (<10 cfu; estimated average 
2 cfu/tube), medium (between 10 to 50 cfu, estimated average 20 cfu/tube), or heavy (>50 cfu; estimated average 
200 cfu/tube). At the time of slaughter, feces were taken from the rectum of each animal and processed within 
48 h after arrival at the laboratory. The fecal samples (2 g each) were decontaminated, blended in a stomacher, and 
cultured in HEYM and LJ, as previously described for tissue culture.
enzyme-linked immunosorbent assay (eLiSA) for the detection of MAp-specific antibod-
ies. Blood was collected from the coccygeal vein of each animal into 4.5 ml serum clot activator Vacutainer® 
tubes (Vacuette, Kremsmunster, Austria). Serum was separated after clotting by centrifugation (2500 × g for 
20 min) and stored at −20 °C until use. The serum samples were tested using the Mycobacterium Paratuberculosis 
Antibody test kit (IDEXX laboratories, Oofddorp, The Netherlands) according to the manufacturer’s instructions. 
The optical density (OD) in each well was measured at 450 nm by an ELISA plate reader (model 680, Sigma, St. 
Lois, MO). The measured ODs were normalized and the results were expressed as a percentage of the positive 
control OD according to the following formula: % relative OD sample/OD positive control = 100 × [(OD sam-
ple+Ag − OD sample−Ag)/(OD mean positive control+Ag − OD mean positive control−Ag).
fecal real-time polymerase chain reaction (pcR). Isolation of genomic DNA from feces was per-
formed using the MagMax Total Nucleic Acid Isolation kit according to the manufacturer’s instructions 
(ThermoFisher Scientific, Lissieu, France). For detection of MAP DNA, the LSI VetMax Triplex real-time PCR 
was used according to the manufacturer’s instructions (ThermoFisher Scientific, Lissieu, France). The kit enables 
real-time PCR detection of Map IS900 and F57 genes in DNA extracted from feces, liquid cultures, and tissues or 
colonies. Real-time PCR amplifications were performed using the MX3000P Real-Time PCR system (Stratagene, 
San Diego, USA) detection system with the following conditions: 1 cycle at 50 °C for 2 min, 1 cycle of 95 °C for 
10 min, 45 cycles of denaturation at 95 °C for 15 s, and annealing/extension at 60 °C for 60 s.
fecal quantitative real-time pcR (qpcR). PCR-positive samples were also tested by real-time qPCR 
using the ParaTB Kuanti-VK kit following the manufacturer’s instructions (Vacunek, Bizkaia, Spain). The kit uses 
a F57 TagMan probe labeled with the fluorescent reporter dye 5-carboxyfluorescein (FAM) at the 5′end and prim-
ers that specifically amplify the single-copy F57 insertion sequence of MAP. Inhibition of the amplification reac-
tion is ruled out by including in the master mix an internal plasmid control with specific primers and an internal 
hybridization probe labeled with 6-carboxy-4′,5′-dichloro-2′,7′-dimethosyfluorescein succinimidyl ester (JOE) 
at the 5′-end. This internal amplification control molecule is co-amplified alongside the F57 diagnostic target in a 
duplex format. Quantification of MAP titer (F57 copy numbers per gram of feces) was accomplished by preparing 
a standard curve using serial dilutions of a standard sample containing a known number of MAP DNA copies. 
Real-time qPCR amplifications were performed using the Step One Plus detection system (Applied Biosystems, 
Carlsbad, CA) with the following conditions: 1 cycle at 95 °C for 10 min, 45 cycles of denaturation at 95 °C for 15 s, 
and annealing/extensions at 60 °C for 60 s. The results were analyzed with the ABI Prism software version 1.4.
RnA extraction and RnA-Seq library preparation. At the time of slaughter, PB samples were collected 
from the coccygeal vein of all the cows included in the study in PAXgene Blood RNA tubes (2.5 ml) (Qiagen, 
Hilden, Germany). Total RNA was extracted from the PB samples using the PAXgene blood RNA kit according 
to the manufacturer’s instructions (Qiagen, Hilden, Germany). For RNA isolation, 150–200 mg of ICV of all the 
animals were harvested and immediately submerged in 2 ml of RNA later (Sigma, St. Louis, MO). Purification of 
RNA was performed using the RNeasy Mini Kit according to the manufacturer’s instructions (Qiagen, Hilden, 
Germany). Residual genomic DNA was removed using DNase digestion with RNase-free DNase I Amplification 
grade following the recommended protocol (Invitrogen, Spain). Concentration and quality of the total RNAs 
were measured using an Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, US). All samples had 
an RNA integrity value of 7 or greater. Approximately 250 ng of RNA were used for each RNA-Seq library crea-
tion using the Illumina NEBNext® Ultra Directional RNA Library preparation kit following the manufacturer’s 
instructions (Illumina Inc, CA, US). All RNA-Seq libraries were quantified using a Qubit® Fluorometer and dou-
bled stranded DNA high Sensitivity Assay Kit (Invitrogen, Spain). RNA-Seq libraries quality was assessed using 
an Agilent Bioanalyzer and Agilent high sensitivity DNA chip to confirm that the insert sizes were 200–250 bp for 
all the individual libraries.
RnA sequencing and bioinformatic analysis of RnA-Seq data. RNA-Seq libraries were single-end 
sequenced in a 1 × 75 format using an Illumina NextSeq500 sequencer at the Genomic Unit of the Scientific 
Park of Madrid, Spain. The raw reads were filtered by their length (minimum size 60 bp long) and percentage of 
ambiguous base N less than 5% using Prinseq-lite52. Trimmed reads were subsequently mapped to the Bos Taurus 
reference genome (Bos_taurus.UMD3.1. version 87) with TopHat mapper53. Reads were assigned to a gene if they 
were not multi-hit reads. The resulting alignment files were provided to Cufflinks to generate a transcriptome 
assembly for each condition. These assemblies were then merged together using Cuffmerge, which is included in 
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the Cufflinks package. This merged assembly provided a uniform basis for calculating gene and transcript expres-
sion levels in each condition. The reads and merged assembly were fed to Cuffdiff which calculates expression 
levels and tested the statistical significance of each observed change in expression54. The fold change (log2 scale), 
P-values and false discovery rates (FDR) for each gene were obtained. The genes with a FDR-adjusted threshold 
<0.05 were considered differentially expressed (DE) when compared to the control group. To visualize and inte-
grate all the data produced by the Cufflink analysis, CummeRbund was used for cluster analysis and for handling 
the transformation of Cuffdiff data into R statistical computing environment. RNA-Seq data have been deposited 
in the NCBI Gene Expression Omnibus (GEO) database under the accession number (GSE137395).
Gene ontology (Go) and metabolic analysis of the De genes obtained using RnA-Seq. To iden-
tify GO and metabolic routes involved in MAP infection, genes with a significant DE in each comparison were 
evaluated using the GOseq R Bioconductor55–57. To begin the analysis, GOseq quantifies the length bias present in 
the DE genes by calculating a probability weighting function (PWF) which gives the probability that a gene will be 
DE based on its length alone. Next, GOseq analysis requires the use of the Wallenius non-central hypergeometric 
distribution to approximate the null distribution for GO category membership and to calculate representation of 
GO categories amongst the set of DE genes. Using the Wallenius approximation, P-values for representation of 
the DE genes in each GO were generated and a P-value threshold <0.05 selected. GO analysis provided categories 
of genes involved in different biological processes (BP), molecular functions (MF) and those integral for different 
cell compartments (CC). KEGG pathways enrichment analysis was also performed using the STRING v11.058.
protein-protein association networks. The DE genes with log2 fold changes >2 or < 2 were analyzed 
using the STRING database v10.559. The STRING database aims to collect, score and integrate all known and 
predicted protein-protein association data. The basic interaction unit in the STRING database is the func-
tional association, i.e. a link between two proteins that both contribute jointly to a specific function. Network 
nodes represent proteins and edges protein-protein interactions. For each interaction a combined and final 
score is computed based on seven evidence channels including neighborhood in the genome, gene fusions, 
co-occurrence across genomes, co-expression, experimental/biochemical data, association in curated databases, 
and co-mentioned in PubMed abstracts. Only functional interactions with a high confidence score (>0.7) were 
included in the networks.
Data Availability
The datasets generated during the current study are available from the corresponding author on reasonable re-
quest.
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